Cluster: Health Economy

Raw milk: regulatory loophole gives Swiss the freedom to skip pasteurisation

This content was published on Oct 8, 2024 The sale of raw milk is banned in some parts of the world but Switzerland counts on labelling and personal responsibility.

Medicines regulators weigh hope and hype with new Alzheimer’s drugs

This content was published on Sep 30, 2024 Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision won’t be easy.

Cosmetic pesticides are making it to your apple. Is that a bad thing?

This content was published on Sep 12, 2024 Plant growth hormones are widely used in fruit cultivation to give consumers uniform, blemish-free products. But with little published research, the risks are as yet unknown.

Food supply chains

Swiss farms make space for beans and lentils

This content was published on Jul 22, 2024 Plant breeders, scientists and farmers in Zurich's countryside try to make the case for legume cultivation.

Battling the rising tide of fake medicine

This content was published on Jul 4, 2024 Sales of counterfeit drugs are booming around the world, putting thousands of lives at risk. Why is it so hard to stem the tide of fake medicine?

What are the ethical considerations in medically assisted reproduction?

Do you think the authorities should allow people diagnosed as infertile to have access to assisted reproductive technology?

Join the discussion

May 27, 2024

8 Likes

9 Comments

View the discussion

Medicine access

Whatever happened to the world’s most expensive drug?

This content was published on Apr 23, 2024 Swiss pharma giant Novartis launched Zolgensma five years ago with a price tag of $2.1 million. What happened to it?

How drug prices are negotiated in Switzerland and beyond

This content was published on Apr 23, 2024 Switzerland's pharmaceutical sector supplies drugs worldwide, but not all countries receive them with the same price tag. Here's why.

Map of Slovenia with pharmaceutical companies locations

Slovenia’s role in the global pharmaceutical supply chain

This content was published on Feb 9, 2024 Novartis and Sandoz have been investing into the Balkan nation's pharma sector, turning into a key partner for development and manufacturing of drugs.

Cluster: Health Economy

Popular Stories

Most Discussed

Cluster: Health Economy

More

Raw milk: regulatory loophole gives Swiss the freedom to skip pasteurisation

More

Medicines regulators weigh hope and hype with new Alzheimer’s drugs

More

Cosmetic pesticides are making it to your apple. Is that a bad thing?

More

Swiss farms make space for beans and lentils

More

Battling the rising tide of fake medicine

More

What are the ethical considerations in medically assisted reproduction?

More

Whatever happened to the world’s most expensive drug?

More

How drug prices are negotiated in Switzerland and beyond

More

Slovenia’s role in the global pharmaceutical supply chain

Popular Stories

Most Discussed